0000939767-16-000290.txt : 20161209 0000939767-16-000290.hdr.sgml : 20161209 20161209200217 ACCESSION NUMBER: 0000939767-16-000290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161209 FILED AS OF DATE: 20161209 DATE AS OF CHANGE: 20161209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Garber Alan M CENTRAL INDEX KEY: 0001312907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 162045059 MAIL ADDRESS: STREET 1: 3355 MILTON COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 4 1 wf-form4_148133172396557.xml FORM 4 X0306 4 2016-12-09 0 0000939767 EXELIXIS, INC. EXEL 0001312907 Garber Alan M C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2016-12-09 4 M 0 10000 10.53 A 69161 D Common Stock 2016-12-09 4 S 0 7832 16.90 D 61329 D Option (right to buy) 10.53 2016-12-09 4 M 0 10000 0 D 2008-05-02 2017-05-01 Common Stock 10000.0 0 D Includes 2,638 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.9001 to $16.9006. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. /s/ Jeffrey J. Hessekiel, Attorney in Fact 2016-12-09